Miyazono Y, Gao F, Horie T
Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba 260-8675, Japan.
Scand J Gastroenterol. 2004 Nov;39(11):1119-27. doi: 10.1080/00365520410003605.
Gastrointestinal toxicity is one of the most serious side effects in the methotrexate (MTX) treatment. However, the mechanism of the toxicity has not been completely clarified, which may be the reason why symptomatic therapy is carried out. On the other hand, the oxidative stress is known to play an important role in various diseases and drug-induced side effects. In this study the focus was on the oxidative stress in order to clarify the mechanism of MTX-induced small intestinal damage, especially neutrophil infiltration.
MTX (20 mg/kg body wt) was administered to rats intravenously. Mucosal homogenates were prepared from the small intestine and used for assay of biochemical parameters, by which induction of oxidative stress and neutrophil infiltration were evaluated. N-acetylcysteine (NAC; 80 mg/kg body wt), an antioxidant or sodium tungstate (tungsten; 0.7 g/kg body wt), an inhibitor of xanthine dehydrogenase (XD)/xanthine oxidase (XO) known as an important source of reactive oxygen species (ROS) was given to rats with MTX to investigate the contribution of ROS to neutrophil infiltration.
The MTX treatment of rats induced the oxidative stress in the small intestine. The ROS production was seen preceding an increase of myeloperoxidase activity, which suggested neutrophil infiltration. Both treatments of NAC and tungsten prevented the MTX-induced ROS production and neutrophil infiltration.
These results suggest that oxidative stress plays an important role in the MTX-induced small intestinal damage, especially neutrophil infiltration. Thus, the modulation of oxidative stress would be useful in reducing intestinal damage in MTX treatment.
胃肠道毒性是甲氨蝶呤(MTX)治疗中最严重的副作用之一。然而,毒性机制尚未完全阐明,这可能是进行对症治疗的原因。另一方面,已知氧化应激在各种疾病和药物引起的副作用中起重要作用。在本研究中,重点关注氧化应激,以阐明MTX诱导的小肠损伤机制,特别是中性粒细胞浸润。
将MTX(20mg/kg体重)静脉注射给大鼠。从小肠制备黏膜匀浆,并用于生化参数测定,通过这些参数评估氧化应激的诱导和中性粒细胞浸润情况。将抗氧化剂N-乙酰半胱氨酸(NAC;80mg/kg体重)或作为活性氧(ROS)重要来源的黄嘌呤脱氢酶(XD)/黄嘌呤氧化酶(XO)抑制剂钨酸钠(钨;0.7g/kg体重)给予接受MTX治疗的大鼠,以研究ROS对中性粒细胞浸润的作用。
MTX治疗大鼠可诱导小肠氧化应激。在髓过氧化物酶活性增加之前可见ROS产生,这提示中性粒细胞浸润。NAC和钨的治疗均能防止MTX诱导的ROS产生和中性粒细胞浸润。
这些结果表明氧化应激在MTX诱导的小肠损伤中起重要作用,尤其是中性粒细胞浸润。因此,调节氧化应激可能有助于减少MTX治疗中的肠道损伤。